New York Cancer Foundation (EIN 463755083) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2013

Legal Domicile

Phone

6317513000

Tax Period

2023-01-01 to 2023-12-31

New York Cancer Foundation, founded in 2013, is a community nonprofit in the Diseases & Disorders sector that reported $1.8M in total revenue in fiscal year 2023. The organization ran a surplus of $474K, a strong 26% operating margin.

Mission

Assist cancer patients undergoing treatment with ancillary bills so they can focus on their recovery

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $948,311

Program Service Revenue $0

Investment Income $0

Other Revenue $900,240

TOTAL REVENUE $1,848,551

Expense Breakdown

Grants Paid $1,181,028

Salaries & Benefits $0

Fundraising Expenses $151,660

Program Expenses $1,181,028

Other Expenses $193,048

TOTAL EXPENSES $1,374,076

Year-over-Year Comparison

	2023	2022	Change
Revenue	$1,848,551	$1,776,543	+0.0%
Expenses	$1,374,076	$1,141,594	+0.2%
Net Income	$474,475	$634,949	-0.3%

Key Indicators

✗ Grants to Organizations ✓ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✗ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

N/A

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
Jeffrey Vacirca	President & CEO	10.00	Director	$0	$0	$0
Nicole Gregrory	Vice Chair	15.00	Director	$0	$0	$0
Robert Nicoletti	Secretary	15.00	Director	$0	$0	$0
Mark Santos	Trustee	5.00	Director	$0	$0	$0
Todd O'Connell	Treasurer	15.00	Director	$0	$0	$0
James Condron	Director	2.00	Director	$0	$0	$0
Bill Peragine	Trustee	5.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$1,848,551	$1,374,076	$2,151,966	$474,475
2022	$1,776,543	$1,141,594	$1,677,491	$634,949
2021	$785,495	$462,264	$1,042,542	$323,231
2020	$308,371	$221,196	$719,311	$87,175
2019	$734,987	$354,670	$632,136	$380,317
2018	$360,581	$196,808	$233,827	$163,773

New York Cancer Foundation